Skip to search formSkip to main contentSkip to account menu

ROCK2 Inhibitor KD025

Known as: SLx2119, SLx 2119, ROCK-II Inhibitor KD025 
An orally administered inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2; ROCK-II), with potential immunomodulating activity. Upon… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Introduction: cGVHD exhibits both autoimmune and fibrotic features across multiple organ systems. KD025 is an orally available… 
2019
2019
ABSTRACT Rho-associated kinases (ROCKs) have been reported to antagonize adipocyte differentiation, and inhibition of ROCKs by… 
2018
2018
Vascular aging fundamentally contributes to large and small vessel disease. Despite the importance of such changes for brain… 
2018
2018
Reducing the activities of the pro‐inflammatory cytokine IL‐17 is an effective treatment strategy for several chronic autoimmune… 
2012
2012
Introduccion: la litiasis urinaria en el nino resulta una enfermedad poco frecuente si se compara con su incidencia en el adulto… 
2009
2009
PURPOSE To compare the efficacy of ureteroscopy and extracorporeal shock wave lithotripsy (ESWL) in treating distal ureteral… 
2005
2005
668 A Ser/Thr kinase ROCK (Rho-associated coiled-coil forming protein kinase) is a downstream effector of small Ras-like GTPase…